NIBEC Co. Ltd (138610) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NIBEC Co. Ltd (138610) has a cash flow conversion efficiency ratio of -0.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.00 Billion ≈ $-2.03 Million USD) by net assets (₩45.82 Billion ≈ $31.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NIBEC Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how NIBEC Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 138610 total liabilities for a breakdown of total debt and financial obligations.
NIBEC Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NIBEC Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asia Sermkij Leasing Public Company Limited
BK:ASK
|
0.261x |
|
Siward Crystal Technology Co Ltd
TW:2484
|
0.029x |
|
PAMT CORP
NASDAQ:PAMT
|
-0.028x |
|
Pyridam Farma Tbk
JK:PYFA
|
-0.213x |
|
Josef Manner & Comp. AG
VI:MAN
|
-0.126x |
|
Loandepot Inc
NYSE:LDI
|
0.100x |
|
China Ecotek Corp
TW:1535
|
0.039x |
|
Sajodaerim
KO:003960
|
0.051x |
Annual Cash Flow Conversion Efficiency for NIBEC Co. Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of NIBEC Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see NIBEC Co. Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩45.82 Billion ≈ $31.05 Million |
₩5.82 Billion ≈ $3.94 Million |
0.127x | +1305.36% |
| 2024-12-31 | ₩32.23 Billion ≈ $21.84 Million |
₩291.25 Million ≈ $197.38K |
0.009x | +113.30% |
| 2023-12-31 | ₩28.84 Billion ≈ $19.55 Million |
₩-1.96 Billion ≈ $-1.33 Million |
-0.068x | -145.98% |
| 2022-12-31 | ₩36.80 Billion ≈ $24.94 Million |
₩5.44 Billion ≈ $3.69 Million |
0.148x | +394.14% |
| 2021-12-31 | ₩27.34 Billion ≈ $18.53 Million |
₩817.97 Million ≈ $554.33K |
0.030x | +289.86% |
| 2020-12-31 | ₩31.84 Billion ≈ $21.58 Million |
₩-501.66 Million ≈ $-339.97K |
-0.016x | +50.23% |
| 2019-12-31 | ₩27.40 Billion ≈ $18.57 Million |
₩-867.62 Million ≈ $-587.97K |
-0.032x | +85.49% |
| 2018-12-31 | ₩10.58 Billion ≈ $7.17 Million |
₩-2.31 Billion ≈ $-1.56 Million |
-0.218x | -578.82% |
| 2017-12-31 | ₩12.36 Billion ≈ $8.38 Million |
₩563.22 Million ≈ $381.68K |
0.046x | +220.46% |
| 2016-12-31 | ₩9.84 Billion ≈ $6.67 Million |
₩-372.21 Million ≈ $-252.24K |
-0.038x | +80.82% |
| 2015-12-31 | ₩10.82 Billion ≈ $7.33 Million |
₩-2.13 Billion ≈ $-1.45 Million |
-0.197x | -10.83% |
| 2014-12-31 | ₩5.08 Billion ≈ $3.44 Million |
₩-903.85 Million ≈ $-612.53K |
-0.178x | -- |
About NIBEC Co. Ltd
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more